Novartis to acquire Chinook Therapeutics in H2 2023



Swiss pharmaceutical giant, Novartis AG, revealed on Monday that it will acquire Seattle-based Chinook Therapeutics for $3.5 billion, with the transaction anticipated to finalize in the second half of…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento